active ingredient semaglutide | Online GLP-1 Prescription Novo Nordisk highlights higher-dose semaglutide

Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) are approved for the treatment of type 2 diabetes (T2D) and obesity, and their safety and tolerability profiles are well established in these populations

Instruct patients to inform healthcare providers prior to any planned surgeries or procedures if they are taking RYBELSUS Adverse Reactions Most common adverse reactions (incidence 5%) are nausea, abdominal pain, diarrhea, decreased appetite, vomiting and constipation Drug Interactions RYBELSUS stimulates insulin release in the presence of elevated blood glucose concentrations

Some weeks youll need more calories, others significantly fewer

Everything included Same price your first month and every month after Never charged for The price you see today is the price you'll pay first month and every month